mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.3 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
0.045 |
0.3 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
0.044 |
0.4 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
0.24 |
0.4 |
mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
-0.18 |
0.4 |